Volume 88 Issue 9 | p. 14 | News of The Week
Issue Date: March 1, 2010

Drug Firms Create Cancer Nonprofit

Research: Lilly, Merck, and Pfizer target disease in Asia
Department: Business
Keywords: precompetitive research, Asia, Enlight Biosciences, PureTech, Sage Bionetworks

In an unusual move, Eli Lilly & Co., Merck & Co., and Pfizer are joining forces to tackle the most common cancers in Asia. The Asian Cancer Research Group (ACRG), a nonprofit, will create a publicly available pharmacogenomic cancer database in hopes that the information will speed the development of diagnostics and treatments for cancer.

Funding for the multi-million-dollar initiative will be provided equally by the three companies, . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society